5 Stocks Raising The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 21 points (0.1%) at 16,093 as of Tuesday, Nov. 26, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,560 issues advancing vs. 1,331 declining with 131 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.1%. Top gainers within the industry include Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.4%, and Agilent Technologies ( A), up 1.1%. On the negative front, top decliners within the industry include ResMed ( RMD), down 2.2%, and Waters Corporation ( WAT), down 1.4%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Opko Health ( OPK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Opko Health is up $0.28 (2.8%) to $10.20 on light volume. Thus far, 1.5 million shares of Opko Health exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $9.89-$10.29 after having opened the day at $10.00 as compared to the previous trading day's close of $9.92.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Opko Health has a market cap of $4.1 billion and is part of the health care sector. Shares are up 107.7% year to date as of the close of trading on Monday. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Blame the Millennials: Cramer's 'Mad Money' Recap (Wednesday 8/9/17)

Biotech Movers: Paratek, Opko, Endo

Insiders Are Loading Up on GE, Twilio & More

Ford Motor, Constellation Brands, Cypress Semiconductor: 'Mad Money' Lightning Round